FEB 15, 2018 9:00 AM PST

What is a CAR-T cell therapy?


Most people must have heard revolutionary cancer therapy called CAR-T cell therapy, a kind of cancer immunotherapy. It has changed the landscape of cancer therapy and has the potential of curing some of the chemotherapy refractory blood cancer such as acute lymphoblastic leukemia (ALL).
Cancer immunotherapy is not a very new science, but it is the culmination of cumulative knowledge gained through countless experiments in immunology and cancer. In 1893, William Coley's observed reduction in tumor size upon injection of streptococcus bacteria. Giving BCG vaccine in early stage of bladder cancer is a form of oldest cancer immunotherapy which is still used in clinical practice.
T cells are the type of a white blood cell which plays an essential role in mounting an appropriate immune response to either diseased cells (virus-infected or cancer cells) or foreign pathogens. Cytotoxic T cells are central in killing cancerous cells. They recognize cancer cells through a particular receptor called T cell receptor (TCR) which binds to the novel antigen expressed only on cancer cells and thereby killing them. However, cytotoxic T cell which can recognize unique tumor antigen is scarce in number, or sometimes tumor itself create microenvironment to decrease their frequency around the tumor microenvironment. One way to overcome this challenge is to engineer T cells ex-vivo isolated from either blood of the patient or healthy individual. In this method, T cells are engineered to produce a single chain variable fragment of an antibody (chimeric antigen receptor; CAR) which recognizes unique antigen only expressed onto tumor cells, e.g., CD19 in case of ALL. They are expended in large number ex-vivo and injected into the patient, where further proliferation produces more engineered T cells specific to tumor cells. Expended CAR-T cells lead to complete killing of all tumor cells without harming healthy normal cells, unlike conventional cancer treatment where most of the side effects come from the killing of healthy cells. However, there are some challenges associated with CAR-T cell therapy such as cytokine storm and expensive nature of its production. Moreover, they are not currently suitable for solid tumors which constitute the majority of cancer found among the population.
FDA has recently approved two CAR-T cell therapy based on CD19 chimeric antigen receptor to treat ALL and diffuse large B cell lymphoma.
About the Author
  • Biological research scientist by profession with passion to write about science in general.
You May Also Like
APR 14, 2020
Plants & Animals
APR 14, 2020
Why Are Bats So Resistant to Viruses?
Bats are some of the most infamous carriers of zoonotic viruses, which are viruses capable of spreading between both ani ...
MAY 17, 2020
Space & Astronomy
MAY 17, 2020
Here's Why it's So Critical That We Understand the Sun
The Sun is just one of countless stars that exist in our universe. But it’s one of the most prominent because it&r ...
MAY 22, 2020
Earth & The Environment
MAY 22, 2020
Mount St. Helens: 40 Years of Recovery
This week marks the 40th anniversary of the Mount St. Helens volcanic eruption in southwestern Washington. According to ...
MAY 24, 2020
Space & Astronomy
MAY 24, 2020
Here's Why SpaceX is Using Heavy Stainless Steel to Make Starship
SpaceX is perhaps best known for its reusable Falcon 9 rocket, the same variety that will be lofting astronauts into out ...
JUN 14, 2020
Plants & Animals
JUN 14, 2020
Giant Hornet Queen Struggles to Establish Her Nest
Giant hornets are among the world’s largest and deadliest hornets, which might explain why they’re so revere ...
JUN 26, 2020
Neuroscience
JUN 26, 2020
Artificial and Natural Neurons Communicate Using Dopamine
Researchers from Stanford University have shown that artificial neurons can communicate with biological neurons with dop ...
Loading Comments...